• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    Three different receptors are used to determine a polyvalent antigen, of which the first and the third are dissolved in a liquid phase and are able to bind to the antigen, the second receptor is present in solid phase and is able to bind to only a part of the first receptor, and the third receptor carries a label and does not cross-react with the first and second receptor, and the antigen is incubated with the first and the third receptor, then the incubation solution is contacted with the second receptor, after which the phases are separated, and the label in one of the phases is measured.
    公开号:SU1475492A3
    申请号:SU843830911
    申请日:1984-12-28
    公开日:1989-04-23
    发明作者:Байер Манфред；Клозе Зигмар；Шлумбергер Хельмут；Клееманн Вольфганг；Паш Манфред；Фит Фридхельм
    申请人:Берингер Маннхайм Гмбх (Фирма)；
    IPC主号:
    专利说明:

    one
    This invention relates to an immunochemical method for determining a polyvalent, at least a bifunctional, ligand (antigen) in a liquid sample.
    The purpose of the invention is to improve the accuracy and simplify the method.
    Example 1. Determination of thyrotropin (TSH).
    First order receptor 1 and receptor 3 (labeled Fab fragments of first order antibodies) originate from the same animal species (mouse); the receptor represents
    Fab fragment labeled Receptor 1 is a monoclonal antibody, the Fab fragment in receptor 3 also originates from a monoclonal antibody (directed against another TSH determinant, than the monoclonal antibody of receptor 1. Receptor 2 originates from a sheep and is directed against Fc part of monoclonal antibody
    MOUSE about
    four
    SL 4b
    WITH
    1C

    cm
    Reagents for carrying out the method
    3147
    Incubation buffer (IP): 15 mmol sodium phosphate buffer, pH 7.14, 154 mmol NaCl, 5 mmol EDTA, 0.2% TSA, pH 7.4.
    Receptor 1 (first order antibodies); anti-TSH - mouse antiserum (receptor 1) ' Monoclonal anti-T8H antibodies containing ascites mouse fluid mixed with up to 1.8 M s (The precipitate is dissolved in a buffer of 15 mmol sodium phosphate, pH 7, 0, and 50 mmol of NOaCI, and the solution thus obtained is subjected to transmission through DEAE-cella xsho zy.
    Receptor 3 (labeled antibodies): Anti-TZN-antibody (monoclonal) that recognizes a different antigen determinate than receptor 1. Peroxidase conjugate (receptor 3): mouse anti-TZN-antisera shorter as purified receptor 1 "Subsequent production (Fab) 2 of the complete molecule
    antibodies are carried out similarly. Horseradish peroxidase binding0
    Receptor 2 (second-order antibodies): a fixed sheep-anti-mouse FcJ adsorbing material - an antibody (receptor 2-adsorber). Sheep antimyxin Fc jf -atsshort is mixed with up to 1.8 M with the precipitate dissolved in buffer 1 or 15 mmol sodium phosphate, pH 7.0 and 50 mmol NaCl and the solution thus obtained is passed through DEAE cellulose. Containing the IgC fraction (receptor 2) is bound to the adsorbent, means, activated with glutaraldehyde Bochringer Mann-helm
    Indicator reagent: 1.8 mmol ABTS, 2 -azino-di (3-ethylbenzthiazoline sulfonate-BU, 3.3 mmol sodium perborate per 100 mmol phosphate-citrate buffer, pH 4.4
    The method is carried out as follows.
    A. 50 ngs of receptor 1 and 170 pg / ml of receptor 3, dissolved in the incubation buffer, are dropped together onto a wire (fibrous mass layer) consisting of 6x6 mm polyester paper, 1.0 mm thick, and

    dried at room temperature. The paper web containing this reagent is called 1 "reactive carrier.

    L A reactive carrier 1 is pipetted with 40 µl of a detectable sample containing a known amount of standard solution antigen, then a batt (layer of pulp) is immediately separated by centrifugation in an Eppendorf centrifuge, the reactive carrier 1 is placed on the Eppendorf cap, and the eluted liquid in the cap (Hiitchen) during centrifugation falls on receptor 2, which is associated with the adsorber, and reacts with it. From receptor 2, 2.5 mg of adsorbed material is used per test.
    The apparatus is shaken and the reaction mixture is incubated for 15 minutes at 37 ° C.
    After 15 minutes, the reaction vessels are removed from the apparatus and centrifuged.
    An aliquot of the supernatant was taken with a pipette and the dye formed was determined by extinction at 405 nm.
    Using two different TSH samples, the following extinction values are determined, which are listed in Table 01. Table 1
    TSH, pMn |
    J405
    NM / CM
    zo
     .,.
    50 55
     The extinction values were determined at a layer thickness of 0.2 cm and were converted to a layer thickness of 1 cm "
    B0 Simple Sandwich (comparison).
    A is carried out, but 2.5 mg of adsorber - receptor 2 is preincubated for 1 hour with 20 µg of receptor 1 in 0.2 ml with shaking. Then the supernatant is sucked off and the residue is washed three times with 1 ml of IP.
    Thus, the adsorber-receptor 2 pre-treated with receptor 1 is incubated for 4 hours with sample and receptor 3 in shaking equipment at 37 ° C, and in this variant the addition of soluble 1 „receptor disappears.
    The supernatant is then aspirated, the residue is washed, and the fixed enzyme activity is determined using an indicator reagent.
    With the help of two different TSH samples, the following extinction values are given, as shown in Table 2.
    table 2
    The sensitivity is much less than according to A.A, although in B.B much more receptor 1 is used than in According to A (1: 400 ratio).
    Example 2. Determination of the human choriogonadotropin (HCG).
    Reagents.
    Buffer A: 100 mmol sodium phosphate pH 7.3 (37 ° C), 2 mmol magnesium chloride, 0.9% NaCl, 0.5% RSA (cattle blood serum albumin).
    120 µg / mp of anti-HCG monoclonal antibody from mouse as ascites (receptor 1) „
    .100 pg / ml (ml anti-HCC-antibody - (sheep) - Pa-fragment-p -galactoside z-conjugate) receptor 3.
    Preparation of the Fab fragment is carried out according to T. Kitagawa.
    The covalet binding of | 5 -galactosidase with the antibody, respectively, with the AK fragment, is carried out according to the method of R.PoPoster.
    Substrate solution: like the buffer, it additionally contains 5 mmol (ONPG) of ortho-nitrophenyl galactoside.
    The preparation of the reactive carrier 1 is carried out analogously to example 1. 40 µl of solution A is dropped on a layer of pulp (web) consisting of polyester paper and then dried at room temperature. Storing a layer of pulp (batting) until its use is carried out at 4 ° C and a relative air humidity of 20%.
    The preparation of reactive carrier 2 on cellulose webs (fibrous mass layer) according to the method of activation with cyanogen bromide is fixed: M - Fc A sheep antibody (lgG fraction), 10 mg of antibody is taken for fixing per gram of fibrous material. Unbound antibody is removed by washing, and the batt (layer of fibrous material) is carefully dried.
    15
    25
    thirty
    20
    at room temperature. The storage of the fibrous material (cords) is carried out similarly to the reactive carrier -1 o
    The HCC is determined using a reactive carrier 1 and 2 described by the device described in the German patent application No. 24250085. The device for performing analytical determinations includes a rotary insert element of centrifugal (centrifugal) analytical automata consisting of a molded body that has a chamber for injecting a sample associated with a plurality of reagent areas containing a suction carrier impregnated with a specific reagent, at least one chamber with a mixing valve and a measuring chamber, which together form the transport path of the test liquid (sample liquid), which goes radially from the inside to, then radially outwards, when the insert is mounted on the rotor, and then at least one or two chambers for receiving liquid, and the transport path that leads from This chamber is dimensioned and at least partially identical to the transport path of the test liquid. At the same time, the transport path of the test liquid goes from the chamber for injecting the sample (P) through the chamber containing q containing the absorbing material. , chamber with and located between the chamber Q and the first valve box
    0 VKY, to the second valve box VK2 and out of it through chamber J and through receiving chamber AK into measuring chamber K. For receiving further liquid, a chamber is provided, which is in the form of a pumping chamber, for the substrate RK, which through the dosing chamber DK and capillary car dosing device and overflow chamber UK are connected to the second valve box VK2,
    In this case, the reactive carrier 1 is placed in the field with a plug-in element
    0
    coping and reactive carrier 2 - in the field d о. The implementation of the reaction corresponds to example 1. At the same time, 40 µl of the sample is pipetted through the opening in the upper part of the edge directly into field 6. The sample is undiluted. High rotational speed
    alternating with the state of rest, then the sample and substrate move in the direction of the separation matrix and cell.
    The transfer of the sample from field c to c is carried out within a very short time (60 s). The leading volume of the substrate to the display is also 40 µl, so that no dilution of the sample takes place before the signal is measured.
    When using calibration serum, a calibration curve is obtained that covers the range of 0-100 pg / ml HCG (ml) standardization according to the 1st IRP standard for HCG, and a sufficiently sensitive measurement of HCG in serum and plasma becomes possible.
    Example 3 Determination of alpha-1-fetoprotein (AFP) 0
    A hapten-labeled receptor 1 is used, all three antibodies derived from the same animal species.
    The implementation and used buffer corresponds to example 2.
    Sheep's anti-APP antibody (100 ng / ml), labeled with digoxin (according to German patent No. 2537129), is used as receptor 1; anti-AFP — sheep antibodies labeled with p-galactosidase according to example 2 is used as receptor 3 , and paper disks made of polyester paper are used as solid-phase receptor 2, with which sheep anti-digoxin antibodies are adsorbed to i. The coating method corresponds to the method known to plastic tubing
    Example 4o Determination of thyrropine (TSH) 0 Reagents.
    Incubation buffer (IP): 15 mmol sodium phosphate buffer, pH 7.4, 154 mmol NaCl, 5 mmol EDTA, 0.2% PSA, pH 7.4o
    Receptor 1: Sheep anti-TSH - antiserum0 Crude serum is mixed with up to 1.8 M with NH4S04o The precipitate is dissolved in a buffer of 15 mmol sodium phosphate, pH 7.0, and 50 mmol NaCl and thus the resulting solution is subjected passing through DEAE pulp. The IgG-containing fraction is then released from the alpha-chain reacting TSH0
    five
    0
    five
    0
    five
    0
    five
    0
    five
    parts by passing through a HCG loaded immuno adsorber. The eluate is fed to a TSH loaded immuno adsorber. After washing the adsorber, immunoreactive against TSH antibodies are eluted with 1 M propionic acid. The eluate is then dialyzed against IP, and is concentrated under known conditions by ultrafiltration.
    Receptor 3: antibody conjugate - peroxidase0 Further sheep anti-TSH - anti-suhour is purified as receptor 1 and then (Fab) 2 fragments are obtained from it. Preparation (Fab) of 2 fragments is carried out according to EoZamoye0
    Receptor 2. The material of the adsorber with fixed donkey-anti-liver FcJ-antibody, Oslin-anti-liver, Fcjf anti-serum is mixed in up to 1.8 M with the precipitate dissolved in a buffer of 15 mmol sodium phosphate, pH 7.0, and 50 mmol of NaCl and the solution thus obtained is passed through DEAE-cellulose0. The IgG-containing fraction (receptor 2) is combined with the adsorbent of the agent activated with glutaraldehyde Boeqringer Mdcpiehga (as defined by jp 665525) according to the manufacturer’s work instructions.
    Indicator reagent: 1.8 mmol ABTS Ј2.2 azino di (3-ethylbenzthiazoline sulfonate-BU, 3.3 mmol sodium perborate per 100 mmol phosphate-citrate buffer, pH 4.4.
    The method is carried out analogously to example 1, in which case the YuOng receptor 1 and 100 pg / ml of receptor 3, dissolved in incubation buffer (40 µl), are dropped onto a cellulose process (fibrous mass layer) measuring 6x6 mm. After drying, the storage of the batt until application is again carried out at 4 ° C.
    Further implementation corresponds to Example 1. 40 µl is used as a sample.
    Thus, the proposed method allows more precise determination of antigens contained in small amounts (40 pg / ml). In addition, a simplification of the method is achieved, since it is not necessary to obtain the first and third receptors from two different species of animals.
    9147549210
    权利要求:
    Claims (1)
    [1]
    Competitive Invention Formula
    The method for determining polyvalent mark, characterized in
    antigen, which includes adding it, in order to improve accuracy and
    to a specific monoclonal anti-simplification method, before adding
    bodies or fragments of antibodies of the first antigen, specific antibodies of the first
    order, second-order antibodies, second-order and labeled Fab fragments
    bound to the solid phase and specificity of these antibodies are applied to the solid phase,
    antibodies fused to the fragments of antibodies are first dried, then after adding
    order, to the Fab fragments of the antitel anti-antigen, the mixture is centrifuged and, on the first order, labeled with a label, the sedimentary liquid is combined with anti-
    followed by the determination of second order antigens.
    类似技术:
    公开号 | 公开日 | 专利标题
    US4434236A|1984-02-28|Immunoassay wherein labeled antibody is displaced from immobilized analyte-analogue
    CA2217818C|2010-10-26|Chemiluminescent immunoassay for antibody detection
    US4659678A|1987-04-21|Immunoassay of antigens
    KR920005963B1|1992-07-25|Method for the determination of a specific binding substance
    US4624930A|1986-11-25|Immunochemical process
    US4943525A|1990-07-24|Simultaneous immunoassay for the determination of antigens and antibodies
    US5770457A|1998-06-23|Rapid oneside single targeting | immunoassay method
    US5188939A|1993-02-23|Displacement immunoassay utilizing an oligavalent labelled antibody
    KR20020028799A|2002-04-17|Immunological analytical method and device for the determination of glycosylated protein
    IE890683L|1989-09-03|Method for determination of a polyvalent substance using an immunoaggregate
    US4670383A|1987-06-02|Immune-chemical measurement process for haptens and proteins
    US5143852A|1992-09-01|Antibodies to ligand analogues and their utility in ligand-receptor assays
    US4880731A|1989-11-14|Process and reagent for the determination of a reaction partner of an immunological reaction
    SU1475492A3|1989-04-23|Method of determining polyvalent antigen
    US5037764A|1991-08-06|Process for determination of an analyte and reagent therefor
    DK165860B|1993-01-25|PROCEDURE FOR DETERMINING A POLYVALENT ANTIGEN AND A REAGENT THEREOF
    US5306622A|1994-04-26|Heterogeneous immunoassay process
    Meriö et al.1996|Monoclonal antibody-based dual-label time-resolved fluorometric assays in a simplified one-step format
    CA2008100A1|1990-07-20|Method for the determination of immunologically detectable substance
    JPH05249113A|1993-09-28|Method and apparatus for separation/analysis
    US4966839A|1990-10-30|Process for the determination of an immunologically bindable analyte
    US4885255A|1989-12-05|Immunochemical process and reagent for the determination of a polyvalent antigen in a liquid sample
    US4786591A|1988-11-22|Process for determining the binding capacity of thyroxin-binding globulin
    EP0338045B1|1994-08-24|Solid-phase non-separation enzyme assay
    JPH063446B2|1994-01-12|Immunoreactive porous carrier materials for heterogeneous immunoassays and methods for their preparation
    同族专利:
    公开号 | 公开日
    JPS60177264A|1985-09-11|
    JPH0521428B2|1993-03-24|
    ZA854B|1985-08-28|
    DE3400027A1|1985-07-18|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    GB2013211B|1978-01-26|1982-06-30|Technicon Instr|Immunoassays using f2 fragments|
    US4292403A|1978-08-24|1981-09-29|Akzona Incorporated|Detection and/or determination of IgM, IgA, IgD and IgE immunoglobulins|
    DE3044385A1|1980-11-25|1982-06-24|Boehringer Mannheim Gmbh, 6800 Mannheim|METHOD FOR CARRYING OUT ANALYTICAL PROVISIONS AND ROTOR INSERT ELEMENT SUITABLE FOR THIS|
    JPS5943360A|1982-09-03|1984-03-10|Olympus Optical Co Ltd|Immunological measuring method|
    EP0105714B1|1982-09-29|1988-07-27|Serono Diagnostics Limited|Immunoassay of antigens|
    DE3400027A1|1984-01-02|1985-07-18|Boehringer Mannheim Gmbh, 6800 Mannheim|Method for the determination of a polyvalent antigen and reagent therefor|
    DE3425008A1|1984-07-06|1986-02-06|Boehringer Mannheim Gmbh, 6800 Mannheim|METHOD AND DEVICE FOR CARRYING OUT ANALYTICAL PROVISIONS|DE3400027A1|1984-01-02|1985-07-18|Boehringer Mannheim Gmbh, 6800 Mannheim|Method for the determination of a polyvalent antigen and reagent therefor|
    GB8607101D0|1986-03-21|1986-04-30|Serono Diagnostics Ltd|Immunoassay|
    DE3714147A1|1987-04-28|1988-11-17|Boehringer Mannheim Gmbh|IMMUNCHEMICAL METHOD AND REAGENT FOR DETERMINING A POLYVALENT ANTIGENT IN A LIQUID SAMPLE|
    DE3718140A1|1987-05-29|1988-12-08|Boehringer Mannheim Gmbh|HETEROGENIC IMMUNOASSAY|
    JP2681370B2|1988-06-30|1997-11-26|塩野義製薬株式会社|Immunoassay|
    DE3836348A1|1988-10-25|1990-04-26|Boehringer Mannheim Gmbh|METHOD FOR DETERMINING AN ANTIQUE CLASS-SPECIFIC ANTIBODY AND REAGENT SUITABLE FOR IT|
    JP2009084961A|2007-10-02|2009-04-23|Annaka Seisakusho:Kk|Locking/unlocking device of overhead door|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    DE19843400027|DE3400027A1|1984-01-02|1984-01-02|Method for the determination of a polyvalent antigen and reagent therefor|
    [返回顶部]